These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9922788)

  • 1. [Combined curietherapy and chemotherapy].
    Mazeron JJ
    Cancer Radiother; 1998 Dec; 2(6):781-2. PubMed ID: 9922788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of concomitant chemoradiotherapy and practical recommendations].
    Bosset JF; Marty M
    Cancer Radiother; 1998 Dec; 2(6):665-7. PubMed ID: 9922770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of radiosensitivity following chemotherapy exposure: potential implications for combined-modality therapy.
    Britten RA
    Cancer Treat Res; 2002; 112():285-303. PubMed ID: 12481721
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
    Adams GE; Stratford IJ; Bremner JC; Edwards HS; Fielden EM
    Radiother Oncol; 1991; 20 Suppl 1():85-91. PubMed ID: 2020774
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical radiosensitization: why it does and does not work.
    Coleman CN; Mitchell JB
    J Clin Oncol; 1999 Jan; 17(1):1-3. PubMed ID: 10458210
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymer-conjugated paclitaxel as a radiosensitizing agent--a big step forward for combined modality therapy?
    Tishler RB
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):563-4. PubMed ID: 12573741
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological principles of chemoradiotherapy].
    Bourhis J; Mornex F
    Cancer Radiother; 1998 Dec; 2(6):657-62. PubMed ID: 9922768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local control of the primary tumor. Necessary step in control of cancer].
    Gérard JP; Roy P; Cucherat M
    Cancer Radiother; 1998 Dec; 2(6):668-71. PubMed ID: 9922771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of radioimmunotherapy in combination with bioreductive agents.
    Langmuir VK
    Recent Results Cancer Res; 1996; 141():137-43. PubMed ID: 8722424
    [No Abstract]   [Full Text] [Related]  

  • 10. Combining radiotherapy with systemic therapies.
    Vokes EE
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):167-9. PubMed ID: 18391914
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical modification of radiation and chemotherapy.
    Brown JM; Hall EJ; Hirst DG; Kinsella TJ; Kligerman MM; Mitchell JB; Travis EJ; Valeriote F
    Am J Clin Oncol; 1988 Jun; 11(3):288-303. PubMed ID: 3289362
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemoradiotherapy in cancers of the uterine cervix].
    Maingon P; Coucke P; Haie-Méder C; Barillot I
    Cancer Radiother; 1998 Dec; 2(6):718-22. PubMed ID: 9922779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in radiosensitization.
    Lawrence TS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):575-7. PubMed ID: 16163239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined chemoradiotherapy of tumors in the child].
    Habrand JL; Oberlin O; Pein F; Leblanc T; Levy-Piedbois C; Doz F
    Cancer Radiother; 1998 Dec; 2(6):752-9. PubMed ID: 9922783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facing fearful odds--a conference summary.
    Hall EJ
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1023-6. PubMed ID: 3744925
    [No Abstract]   [Full Text] [Related]  

  • 16. [Present status of radiotherapy of malignant tumors and basic trends in its development].
    Pereslegin IA; Zolotkov AG
    Vestn Rentgenol Radiol; 1983; (6):5-10. PubMed ID: 6429926
    [No Abstract]   [Full Text] [Related]  

  • 17. International Clinical Trials in Radiation Oncology. Chemical modifiers.
    Bartelink H; Bleehen NM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S39-49. PubMed ID: 3292481
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemoradiotherapy: history and state of the art].
    Cosset JM
    Cancer Radiother; 1998 Dec; 2(6):653-6. PubMed ID: 9922767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New radiosensitizing regimens, drugs, prodrugs, and candidates.
    Vallerga AK; Zarling DA; Kinsella TJ
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of anticancer chemotherapy. Progress in concept, methods and means].
    Chauvergne J
    Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):271-89. PubMed ID: 897407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.